======= TFDP2 ======= == Gene Information == * **Official Symbol**: TFDP2 * **Official Name**: transcription factor Dp-2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7029|7029]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14188|Q14188]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TFDP2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TFDP2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602160|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |E2F TDP| |DP| |regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway| |positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway| |regulation of transcription involved in G1/S transition of mitotic cell cycle| |positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway| |negative regulation of G0 to G1 transition| |regulation of G0 to G1 transition| |regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway| |DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest| |intracellular signal transduction involved in G1 DNA damage checkpoint| |signal transduction involved in mitotic DNA integrity checkpoint| |signal transduction involved in mitotic G1 DNA damage checkpoint| |signal transduction involved in mitotic cell cycle checkpoint| |signal transduction involved in mitotic DNA damage checkpoint| |positive regulation of establishment of protein localization to mitochondrion| |mitotic G1 DNA damage checkpoint| |mitotic G1/S transition checkpoint| |G1 DNA damage checkpoint| |RNA polymerase II transcription factor complex| |signal transduction involved in DNA damage checkpoint| |signal transduction involved in DNA integrity checkpoint| |regulation of mitochondrial membrane permeability| |regulation of establishment of protein localization to mitochondrion| |signal transduction involved in cell cycle checkpoint| |DNA damage response, signal transduction by p53 class mediator| |positive regulation of cell cycle arrest| |regulation of membrane permeability| |transcription coregulator activity| |mitotic DNA damage checkpoint| |negative regulation of G1/S transition of mitotic cell cycle| |mitotic DNA integrity checkpoint| |signal transduction in response to DNA damage| |negative regulation of cell cycle G1/S phase transition| |regulation of cell cycle arrest| |positive regulation of mitochondrion organization| |G1/S transition of mitotic cell cycle| |signal transduction by p53 class mediator| |cell cycle G1/S phase transition| |positive regulation of protein localization to membrane| |mitochondrial membrane organization| |DNA damage checkpoint| |DNA integrity checkpoint| |regulation of G1/S transition of mitotic cell cycle| |mitotic cell cycle checkpoint| |regulation of cell cycle G1/S phase transition| |positive regulation of apoptotic signaling pathway| |regulation of mitochondrion organization| |regulation of protein localization to membrane| |cell cycle checkpoint| |negative regulation of mitotic cell cycle phase transition| |mitochondrial transport| |negative regulation of cell cycle phase transition| |protein domain specific binding| |mitotic cell cycle phase transition| |cell cycle phase transition| |positive regulation of cell cycle process| |negative regulation of mitotic cell cycle| |RNA polymerase II regulatory region sequence-specific DNA binding| |positive regulation of cellular protein localization| |negative regulation of cell cycle process| |transcription factor binding| |positive regulation of cell cycle| |regulation of apoptotic signaling pathway| |regulation of mitotic cell cycle phase transition| |mitochondrion organization| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of cell cycle phase transition| |positive regulation of establishment of protein localization| |heart development| |regulation of cellular protein localization| |negative regulation of cell cycle| |mitotic cell cycle process| |positive regulation of organelle organization| |regulation of mitotic cell cycle| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |DNA-binding transcription factor activity| |mitotic cell cycle| |positive regulation of cell death| |regulation of establishment of protein localization| |regulation of cell cycle process| |cellular response to DNA damage stimulus| |membrane organization| |circulatory system development| |regulation of cellular localization| |positive regulation of transport| |cell cycle process| |regulation of protein localization| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |mitochondrion| |regulation of organelle organization| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|-1.88| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|-1.77| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|1.7| |[[:results:exp436|Dynasore 7μM R08 exp436]]|1.81| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|1.88| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.94| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.94| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.97| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|1.99| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|2.3| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.3| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.42| ^Gene^Correlation^ |[[:human genes:t:tfdp1|TFDP1]]|0.451| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17848 * **Expression level (log2 read counts)**: 7.54 {{:chemogenomics:nalm6 dist.png?nolink |}}